2021
HEMORRHAGIC OCCLUSIVE RETINAL VASCULITIS AFTER INTRACAMERAL VANCOMYCIN USE IN CATARACT SURGERY AFTER INTRAVENOUS EXPOSURE
Alasil T, Wong JJY, Adelman RA, Tom D, Coady PA. HEMORRHAGIC OCCLUSIVE RETINAL VASCULITIS AFTER INTRACAMERAL VANCOMYCIN USE IN CATARACT SURGERY AFTER INTRAVENOUS EXPOSURE. Retinal Cases & Brief Reports 2021, Publish Ahead of Print: &na;. PMID: 29474222, DOI: 10.1097/icb.0000000000000725.Peer-Reviewed Original ResearchConceptsHemorrhagic occlusive retinal vasculitisOcclusive retinal vasculitisCataract surgeryLeft eyeIntracameral vancomycinRetinal vasculitisSystemic vancomycinHypersensitivity reactionsPan-retinal photocoagulationPeripheral retinal hemorrhagesFavorable visual outcomeUncomplicated cataract surgeryOral prednisoneFundus examinationRetinal ischemiaVisual outcomeFellow eyesInfection prophylaxisRetinal hemorrhagesBlurry visionVisual acuityAnterior chamberIntraocular lensIschemic areaVasculitis cases
2020
Clinical Etiologies, Microbial Spectrum, Antibiotic Susceptibilities, and Visual Acuity Outcomes of Acute Endophthalmitis
Lu LJ, Chen X, Adelman RA. Clinical Etiologies, Microbial Spectrum, Antibiotic Susceptibilities, and Visual Acuity Outcomes of Acute Endophthalmitis. Journal Of Ocular Pharmacology And Therapeutics 2020, 36: 534-539. PMID: 32609038, DOI: 10.1089/jop.2018.0074.Peer-Reviewed Original ResearchConceptsVisual acuity outcomesClinical etiologyAntibiotic susceptibilityMicrobial spectrumAcute endophthalmitisAcuity outcomesPostoperative infectionCorneal ulcersCataract extractionEtiology of endophthalmitisFinal VA outcomesTertiary referral centerMajority of patientsRetrospective chart reviewICD-10 codesSpectrum of pathogensCommon inciting factorCulture-proven endophthalmitisChart reviewReferral centerVisual outcomeVA outcomesExogenous endophthalmitisClinical recordsMedical recordsThe new Myopic Traction Maculopathy Staging System
Parolini B, Palmieri M, Finzi A, Besozzi G, Lucente A, Nava U, Pinackatt S, Adelman R, Frisina R. The new Myopic Traction Maculopathy Staging System. European Journal Of Ophthalmology 2020, 31: 1299-1312. PMID: 32506945, DOI: 10.1177/1120672120930590.Peer-Reviewed Original ResearchVISUAL OUTCOME OF EARLY VITRECTOMY AND INTRAVITREAL ANTIBIOTICS IN ACUTE POSTSURGICAL AND POSTINTRAVITREAL INJECTION ENDOPHTHALMITIS: European Vitreo-Retinal Society Endophthalmitis Study Report Two.
Soliman MK, Gini G, Kuhn F, Parolini B, Ozdek S, Adelman RA, Sallam AB. VISUAL OUTCOME OF EARLY VITRECTOMY AND INTRAVITREAL ANTIBIOTICS IN ACUTE POSTSURGICAL AND POSTINTRAVITREAL INJECTION ENDOPHTHALMITIS: European Vitreo-Retinal Society Endophthalmitis Study Report Two. Retina 2020, 41: 423-430. PMID: 32467482, DOI: 10.1097/iae.0000000000002856.Peer-Reviewed Original ResearchConceptsIntravitreal antibioticsPPV groupEarly PPVVisual outcomeRetinal detachmentPostintravitreal injection endophthalmitisRetrospective multicenter cohortFinal visual acuityWeeks of presentationDays of presentationMethod of treatmentEarly vitrectomyMulticenter cohortIntravitreal injectionPlana vitrectomyRetina specialistsVisual acuityMean ageIntraocular proceduresEndophthalmitisSimilar outcomesLight perceptionEyesVitrectomyOutcomes
2019
Retinal and Ophthalmic Artery Occlusions Preferred Practice Pattern®
Flaxel CJ, Adelman RA, Bailey ST, Fawzi A, Lim JI, Vemulakonda GA, Ying GS. Retinal and Ophthalmic Artery Occlusions Preferred Practice Pattern®. Ophthalmology 2019, 127: p259-p287. PMID: 31757501, DOI: 10.1016/j.ophtha.2019.09.028.Peer-Reviewed Original ResearchPanretinal Photocoagulation along the Long Ciliary Nerve in Diabetic Retinopathy
Lu AJ, Freedman IG, Shakir O, Adelman RA, Del Priore LV. Panretinal Photocoagulation along the Long Ciliary Nerve in Diabetic Retinopathy. Ophthalmology Retina 2019, 3: 1105-1107. PMID: 31519540, DOI: 10.1016/j.oret.2019.07.002.Peer-Reviewed Original ResearchResponse to Vitrectomy in diabetic macular edema
Michalewska Z, Stewart MW, Landers MB, Bednarski M, Adelman RA, Nawrocki J. Response to Vitrectomy in diabetic macular edema. Canadian Journal Of Ophthalmology 2019, 54: 403-404. PMID: 31109488, DOI: 10.1016/j.jcjo.2019.04.007.Peer-Reviewed Original Research
2017
Vitrectomy in the management of diabetic macular edema in treatment-naïve patients
Michalewska Z, Stewart MW, Landers MB, Bednarski M, Adelman RA, Nawrocki J. Vitrectomy in the management of diabetic macular edema in treatment-naïve patients. Canadian Journal Of Ophthalmology 2017, 53: 402-407. PMID: 30119796, DOI: 10.1016/j.jcjo.2017.10.011.Peer-Reviewed Original ResearchConceptsTreatment-naïve diabetic macular edemaDiabetic macular edemaCentral retinal thicknessPars plana vitrectomyMacular edemaVisual acuityPlana vitrectomyMean central retinal thicknessDuration of diabetesProspective randomized trialsTreatment-naïve patientsInitial visual acuityVisual acuity changesPrimary outcome measureEfficacy of vitrectomyElectronic medical recordsEarly vitrectomyIntravitreal bevacizumabFinal BCVAMean BCVAPrimary endpointRetinal thicknessConsecutive patientsRandomized trialsRetrospective studyAge‐related macular degeneration: using morphological predictors to modify current treatment protocols
Ashraf M, Souka A, Adelman RA. Age‐related macular degeneration: using morphological predictors to modify current treatment protocols. Acta Ophthalmologica 2017, 96: 120-133. PMID: 29130626, DOI: 10.1111/aos.13565.Peer-Reviewed Original ResearchConceptsAge-related macular degenerationPigment epithelial detachmentChoroidal neovascular membranePosterior vitreous detachmentNeovascular age-related macular degenerationRetinal angiomatous proliferationSubretinal fluidIntraretinal cystsVitreomacular adhesionVisual outcomeVisual acuityPrognostic indicatorMacular degenerationAnti-vascular endothelial growth factorLarger choroidal neovascular membranesWet age-related macular degenerationOlder ageCNV sizeFinal visual outcomeGood visual outcomeAnti-VEGF therapyPoor prognostic indicatorCurrent treatment protocolsEndothelial growth factorInjection frequencyAsymmetric Deep Stromal Keratopathy in a Patient With Multiple Myeloma
Tainsh LT, Coady PA, Sinard JH, Neparidze N, Meskin SW, Adelman RA, Chow J. Asymmetric Deep Stromal Keratopathy in a Patient With Multiple Myeloma. Cornea 2017, 36: 372-374. PMID: 28079685, DOI: 10.1097/ico.0000000000001139.Peer-Reviewed Original ResearchConceptsMultiple myelomaVisual acuityRight eye 2 yearsDeep stromal opacitiesEye 2 yearsPatient's visual acuityDiagnosis of IgGParaproteinemic keratopathyInitial presentationStromal lesionsStromal opacityCase reportHematologic workupMonoclonal gammopathyAsymmetric presentationUnusual casePosterior stromaMyelomaKeratopathyPatientsDiagnosisPresentationLiterature reviewKeratoplastyAcuity
2016
Hyperacuity Exam Screens for Choroidal Neovascularization in Age-Related Macular Degeneration on a Mobile Device.
Chen JS, Adelman RA. Hyperacuity Exam Screens for Choroidal Neovascularization in Age-Related Macular Degeneration on a Mobile Device. Ophthalmic Surgery Lasers And Imaging Retina 2016, 47: 708-15. PMID: 27548447, DOI: 10.3928/23258160-20160808-03.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overChoroidChoroidal NeovascularizationComputers, HandheldCross-Sectional StudiesEquipment DesignFemaleFluorescein AngiographyFundus OculiHumansMacular DegenerationMaleMiddle AgedMobile ApplicationsMonitoring, PhysiologicReproducibility of ResultsTomography, Optical CoherenceVisual AcuityConceptsAge-related macular degenerationChoroidal neovascularizationMacular degenerationSpectral-domain optical coherence tomographySingle-center studyProgression of diseaseOptical coherence tomographyChart reviewTimely treatmentPatientsCoherence tomographyNeovascularizationPatient informationSame dayTreatmentPotential screenFurther dataHuman Research Protection ProgramDegenerationSubspecialistsDiseaseProgressionPredicting outcomes to anti-vascular endothelial growth factor (VEGF) therapy in diabetic macular oedema: a review of the literature
Ashraf M, Souka A, Adelman R. Predicting outcomes to anti-vascular endothelial growth factor (VEGF) therapy in diabetic macular oedema: a review of the literature. British Journal Of Ophthalmology 2016, 100: 1596. PMID: 27231313, DOI: 10.1136/bjophthalmol-2016-308388.Peer-Reviewed Original ResearchConceptsDiabetic macular edemaOptical coherence tomographyMacular edemaAnti-vascular endothelial growth factor therapyIntravitreal anti-vascular endothelial growth factorAnti-vascular endothelial growth factorEndothelial growth factor therapyFluorescein angiography findingsAnti-VEGF therapyAnti-VEGF agentsGrowth factor therapyCourse of treatmentCommon prognostic indicatorsEndothelial growth factorFactor therapyMost patientsVisual outcomeAngiography findingsChoroidal thicknessLarge RCTsTreatment regimenOCT parametersVisual acuityPrognostic indicatorDifferent RCTs
2015
Primary rhegmatogenous retinal detachment repair: evidence supports an individualised approach
Wykoff CC, Schwartz SG, Adelman RA, Brucker AJ, Flynn HW. Primary rhegmatogenous retinal detachment repair: evidence supports an individualised approach. British Journal Of Ophthalmology 2015, 99: 1451. PMID: 26347529, DOI: 10.1136/bjophthalmol-2015-307651.Peer-Reviewed Original ResearchTEMPORAL INVERTED INTERNAL LIMITING MEMBRANE FLAP TECHNIQUE VERSUS CLASSIC INVERTED INTERNAL LIMITING MEMBRANE FLAP TECHNIQUE
Michalewska Z, Michalewski J, Dulczewska-Cichecka K, Adelman RA, Nawrocki J. TEMPORAL INVERTED INTERNAL LIMITING MEMBRANE FLAP TECHNIQUE VERSUS CLASSIC INVERTED INTERNAL LIMITING MEMBRANE FLAP TECHNIQUE. Retina 2015, 35: 1844-1850. PMID: 25946691, DOI: 10.1097/iae.0000000000000555.Peer-Reviewed Original ResearchConceptsILM flap techniqueFlap techniqueMacular holeGroup BGroup AOptic nerve fiber layer appearanceProspective comparative interventional studyFinal visual acuityINTERNAL LIMITING MEMBRANE FLAPIdiopathic macular holeNumber of patientsComparative interventional studyStage IV macular holesInternal Limiting MembranePostoperative examinationConsecutive eyesVisual acuityInterventional studyTemporal sideGroup A.ILM flapTreatment groupsMembrane flapSatisfactory outcomeLimiting MembraneCHOROIDAL THICKNESS MEASURED WITH SWEPT SOURCE OPTICAL COHERENCE TOMOGRAPHY BEFORE AND AFTER VITRECTOMY WITH INTERNAL LIMITING MEMBRANE PEELING FOR IDIOPATHIC EPIRETINAL MEMBRANES
Michalewska Z, Michalewski J, Adelman RA, Zawilak E, Nawrocki J. CHOROIDAL THICKNESS MEASURED WITH SWEPT SOURCE OPTICAL COHERENCE TOMOGRAPHY BEFORE AND AFTER VITRECTOMY WITH INTERNAL LIMITING MEMBRANE PEELING FOR IDIOPATHIC EPIRETINAL MEMBRANES. Retina 2015, 35: 487-491. PMID: 25322467, DOI: 10.1097/iae.0000000000000350.Peer-Reviewed Original ResearchConceptsIdiopathic epiretinal membraneOuter choroidoscleral boundaryChoroidal thicknessFellow eyesEpiretinal membraneMembrane peelingINTERNAL LIMITING MEMBRANE PEELINGPatient's fellow eyeUnaffected fellow eyesPars plana vitrectomyChoroidal thickness measurementsRetinal pigment epitheliumSource optical coherence tomographyOptical coherence tomographySuprachoroidal layerOperated eyesRetinal arteryPlana vitrectomyProspective studyERM removalPigment epitheliumHyperreflective bandSource optical coherence tomography imagesCoherence tomographySuprachoroidal spaceStrategy for the Management of Macular Edema in Retinal Vein Occlusion: The European VitreoRetinal Society Macular Edema Study
Adelman RA, Parnes AJ, Bopp S, Othman I, Ducournau D. Strategy for the Management of Macular Edema in Retinal Vein Occlusion: The European VitreoRetinal Society Macular Edema Study. BioMed Research International 2015, 2015: 870987. PMID: 25705695, PMCID: PMC4325227, DOI: 10.1155/2015/870987.Peer-Reviewed Original ResearchConceptsRetinal vein occlusionCentral retinal vein occlusionBranch retinal vein occlusionVein occlusionMacular edemaVisual acuityIntravitreal antivascular endothelial growth factor injectionsAntivascular endothelial growth factor injectionsCases of RVOEndothelial growth factor injectionsGrowth factor injectionsChoice of treatmentMulticenter collaborative studyEdema studyFactor injectionsNonsurgical treatmentNumber of treatmentsVEGF injectionPlana vitrectomyRVO casesILM peelingRetina specialistsVisual gainDiagnostic findingsVisual improvementStrategy for the Management of Diabetic Macular Edema: The European Vitreo‐Retinal Society Macular Edema Study
Adelman R, Parnes A, Michalewska Z, Parolini B, Boscher C, Ducournau D. Strategy for the Management of Diabetic Macular Edema: The European Vitreo‐Retinal Society Macular Edema Study. BioMed Research International 2015, 2015: 352487. PMID: 25695062, PMCID: PMC4324105, DOI: 10.1155/2015/352487.Peer-Reviewed Original ResearchMeSH KeywordsBasement MembraneDiabetic RetinopathyDisease ManagementHumansMacular EdemaRetinaVisual AcuityVitrectomyConceptsDiabetic macular edemaMacular edemaVisual acuityVisual improvementBetter visual improvementMulticenter clinical studyPars plana vitrectomySignificant visual improvementEdema studyTriamcinolone monotherapyVEGF therapyVEGF injectionVision gainClinical findingsGrid laserPlana vitrectomyRetina specialistsClinical studiesDifferent therapiesClinical informationEdemaAcuityTherapyMean numberTreatmentRecent developments in laser treatment of diabetic retinopathy
Yun SH, Adelman RA. Recent developments in laser treatment of diabetic retinopathy. Middle East African Journal Of Ophthalmology 2015, 22: 157-163. PMID: 25949072, PMCID: PMC4411611, DOI: 10.4103/0974-9233.150633.Peer-Reviewed Original ResearchConceptsDiabetic retinopathyAntivascular endothelial growth factor therapyEndothelial growth factor therapyProliferative diabetic retinopathyGrowth factor therapyPattern scan laserDiabetic retinopathy treatmentLaser treatmentFactor therapyMacular edemaLaser photocoagulationRetinopathy treatmentLaser therapyRetinopathyScan laserTherapyTreatmentEdemaPhotocoagulationMainstay
2014
Aflibercept in the Treatment of Neovascular Age-Related Macular Degeneration in Previously Treated Patients
Hall LB, Zebardast N, Huang JJ, Adelman RA. Aflibercept in the Treatment of Neovascular Age-Related Macular Degeneration in Previously Treated Patients. Journal Of Ocular Pharmacology And Therapeutics 2014, 30: 346-352. PMID: 24552305, DOI: 10.1089/jop.2013.0188.Peer-Reviewed Original ResearchMeSH KeywordsAged, 80 and overAntibodies, Monoclonal, HumanizedBevacizumabFemaleHumansIntravitreal InjectionsMacular DegenerationMaleRanibizumabReceptors, Vascular Endothelial Growth FactorRecombinant Fusion ProteinsRetinaRetrospective StudiesTomography, Optical CoherenceTreatment OutcomeVascular Endothelial Growth Factor AVisual AcuityConceptsAge-related macular degenerationCentral macular thicknessAflibercept injectionsInitial visitMacular degenerationAnti-vascular endothelial growth factor treatmentNeovascular age-related macular degenerationEndothelial growth factor treatmentCentral macular edemaIntraocular pressure increaseSubset of patientsMain outcome measuresOptical coherence tomographyGrowth factor treatmentMacular thicknessNeovascular AgeOcular hypertensionSubmacular fluidVisual outcomeMacular edemaRetrospective studyVisual acuityOutcome measuresStudy populationPatients
2013
Prevalence of Ocular Manifestations of HIV/AIDS in the Highly Active Antiretroviral Therapy (HAART) Era: A Different Spectrum in Central South China
Luo J, Jing D, Kozak I, Huiming Z, Siying C, Yezhen Y, xin Q, Luosheng T, Adelman RA, Forster SH. Prevalence of Ocular Manifestations of HIV/AIDS in the Highly Active Antiretroviral Therapy (HAART) Era: A Different Spectrum in Central South China. Ophthalmic Epidemiology 2013, 20: 170-175. PMID: 23713918, DOI: 10.3109/09286586.2013.789530.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAntiretroviral Therapy, Highly ActiveAsian PeopleCD4 Lymphocyte CountCD4-Positive T-LymphocytesChildChinaCross-Sectional StudiesCytomegalovirus RetinitisEye Infections, ViralFemaleHIV InfectionsHumansMaleMiddle AgedPrevalenceRetinal DiseasesRisk FactorsVisual AcuityYoung AdultConceptsHIV/AIDSOcular manifestationsActive antiretroviral therapy (HAART) eraHuman immunodeficiency virus/Antiretroviral therapy eraActive antiretroviral therapyRoutine ophthalmic examinationEra of HAARTPrevalence of HIVCross-sectional studyHIV retinopathyTherapy eraAntiretroviral therapyCommon HIVCytomegalovirus retinitisOcular complicationsOcular examinationOcular findingsImmunodeficiency syndromeOcular lesionsOphthalmic examinationVirus/Epidemiologic studiesHigh riskOcular diseases